We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.9B
AUM Growth
+$82.9M
Cap. Flow
-$1.22B
Cap. Flow %
-8.19%
Top 10 Hldgs %
17.88%
Holding
1,150
New
131
Increased
316
Reduced
491
Closed
190

Top Buys

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$108M
2
T icon
AT&T
T
+$102M
3
VLO icon
Valero Energy
VLO
+$70.6M
4
MPC icon
Marathon Petroleum
MPC
+$53.5M
5
BMY icon
Bristol-Myers Squibb
BMY
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Healthcare 14.02%
3 Consumer Discretionary 12.92%
4 Financials 11.35%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCTL
1101
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
-684,104
Closed -$1.41M
ARAV
1102
DELISTED
Aravive, Inc. Common Stock
ARAV
-12,127
Closed -$45K
SRT
1103
DELISTED
Startek Inc.
SRT
-41,010
Closed -$226K
HALL
1104
DELISTED
Hallmark Financial Services, Inc.
HALL
-12,434
Closed -$454K
PCTI
1105
DELISTED
PCTEL, Inc. Common Stock
PCTI
-23,837
Closed -$148K
CTG
1106
DELISTED
Computer Task Group, Inc.
CTG
-45,084
Closed -$360K
NEWR
1107
DELISTED
New Relic, Inc.
NEWR
-505,845
Closed -$36.3M
LSI
1108
DELISTED
Life Storage, Inc.
LSI
-13,755
Closed -$1.58M
STSA
1109
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
-78,535
Closed -$366K
MNTV
1110
DELISTED
Momentive Global Inc. Common Stock
MNTV
-46,720
Closed -$916K
LABP
1111
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
-1,817
Closed -$265K
CDAK
1112
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
-22,129
Closed -$361K
IAA
1113
DELISTED
IAA, Inc. Common Stock
IAA
-63,280
Closed -$3.45M
CNCE
1114
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-366,448
Closed -$1.2M
ELVT
1115
DELISTED
Elevate Credit, Inc.
ELVT
-555,146
Closed -$2.29M
LHCG
1116
DELISTED
LHC Group LLC
LHCG
-4,054
Closed -$636K
LCI
1117
DELISTED
Lannett Company, Inc.
LCI
-254,561
Closed -$3.06M
OYST
1118
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
-31,204
Closed -$370K
ABMD
1119
DELISTED
Abiomed Inc
ABMD
-15,235
Closed -$4.96M
AGTC
1120
DELISTED
Applied Genetic Technologies Corporation
AGTC
-348,560
Closed -$1.05M
PHAS
1121
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
-31,324
Closed -$97K
EXTN
1122
DELISTED
Exterran Corporation
EXTN
-54,078
Closed -$240K
TMX
1123
DELISTED
Terminix Global Holdings, Inc.
TMX
-5,060
Closed -$211K
HNGR
1124
DELISTED
Hanger Inc.
HNGR
-18,539
Closed -$407K
ATHX
1125
DELISTED
Athersys, Inc. Common Stock
ATHX
-5,278
Closed -$175K

Similar funds

Jacobs Levy Equity Management's Q4 2021 Portfolio in Review

As of Q4 2021, Jacobs Levy Equity Management held 1,150 positions worth $14.9B, up 0.56% from $14.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Jacobs Levy Equity Management withdrew a net $1.22B in Q4 2021, closing 190 positions and reducing 491 holdings. Its most notable exit was Cerner Corp, an estimated $46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Jacobs Levy Equity Management opened a new position in Booking.com worth $109M.

  • Jacobs Levy Equity Management's largest Q4 2021 buy was Booking.com: 1,135,900 shares worth $109M.
  • Jacobs Levy Equity Management added most to AT&T in Q4 2021, an estimated $102M increase.
  • Jacobs Levy Equity Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $89.1M.
  • Jacobs Levy Equity Management fully exited Cerner Corp in Q4 2021, selling an estimated $46M.
  • Jacobs Levy Equity Management's ten largest holdings make up 18% of its $14.9B portfolio in Q4 2021.
  • Jacobs Levy Equity Management opened 131 new positions and closed 190 in Q4 2021.
  • Jacobs Levy Equity Management's portfolio value rose 0.56% quarter-over-quarter to $14.9B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.